Doctors are reporting a new gain in breast cancer treatment. Some HER2 negative breast cancers are actually “HER2 low” and can benefit from a drug targeting the HER2 protein.
About half of patients with late-stage breast cancer formerly categorized as HER2-negative may actually be HER2-low and eligible for the drug.
In the new study, the drug lengthened the time patients lived without their cancer progressing and improved survival compared with patients given standard chemotherapy. Now, it will be important to define the HER2 gray area to make sure the right patients receive the treatment and then to monitor them closely, experts said.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Drug could help thousands with advanced breast cancer, researchers sayThe latest gain for targeted cancer therapy could open new treatment possibilities to thousands of patients with advanced breast cancer.
Weiterlesen »
Researchers: Breast cancer drug could help more patientsDoctors are reporting a new gain in breast cancer treatment.
Weiterlesen »
Drug could help thousands with advanced breast cancer, researchers sayThe latest gain for targeted cancer therapy could open new treatment possibilities to thousands of patients with advanced breast cancer.
Weiterlesen »
New gallery exhibition explores postpartum with AI and synthetic breast milkScience-influenced artist Ani Liu became a parent shortly before the pandemic, and she channeled that experience into a new show called “Ecologies of Care.”
Weiterlesen »
Breast-Feeding the MicrobiomeWhy human breast milk is a scientific marvel.
Weiterlesen »
Chrissy Teigen, Ayesha Curry, & More Celebrity Women Who Had Their Breast Implants RemovedFrom ayeshacurry to most recently DanicaPatrick, many celebrity women have bravely opened up about the decision to remove their breast implants. See what they said below!
Weiterlesen »